Talbot TR - Search Results

1

Asthma as a risk factor for invasive pneumococcal disease.

Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, Schaffner W, Craig AS, Griffin MR. Talbot TR, et al. N Engl J Med. 2005 May 19;352(20):2082-90. doi: 10.1056/NEJMoa044113. N Engl J Med. 2005. PMID: 15901861 Free article.

2

Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.

Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Talbot TR, et al. Pediatr Infect Dis J. 2004 Aug;23(8):726-31. doi: 10.1097/01.inf.0000133046.60555.de. Pediatr Infect Dis J. 2004. PMID: 15295222

3

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.

Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Talbot TR, et al. Clin Infect Dis. 2004 Sep 1;39(5):641-8. doi: 10.1086/422653. Epub 2004 Aug 16. Clin Infect Dis. 2004. PMID: 15356776

4

Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation.

Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR. Talbot TR, et al. Am J Med. 2005 Mar;118(3):285-91. doi: 10.1016/j.amjmed.2004.09.016. Am J Med. 2005. PMID: 15745727

5

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W. Poehling KA, et al. Among authors: talbot tr. JAMA. 2006 Apr 12;295(14):1668-74. doi: 10.1001/jama.295.14.1668. JAMA. 2006. PMID: 16609088

6

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Halasa NB, Shankar SM, Talbot TR, Arbogast PG, Mitchel EF, Wang WC, Schaffner W, Craig AS, Griffin MR. Halasa NB, et al. Among authors: talbot tr. Clin Infect Dis. 2007 Jun 1;44(11):1428-33. doi: 10.1086/516781. Epub 2007 Apr 18. Clin Infect Dis. 2007. PMID: 17479937

7

Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.

Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W. Halasa NB, et al. Among authors: talbot tr. Pediatr Infect Dis J. 2013 Jun;32(6):604-9. doi: 10.1097/INF.0b013e318287fe0d. Pediatr Infect Dis J. 2013. PMID: 23348816

8

Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.

Daniels TL, Deppen S, Arbogast PG, Griffin MR, Schaffner W, Talbot TR. Daniels TL, et al. Among authors: talbot tr. Infect Control Hosp Epidemiol. 2008 Nov;29(11):1080-3. doi: 10.1086/591456. Infect Control Hosp Epidemiol. 2008. PMID: 18837670

9

Adherence to perinatal group B streptococcal prevention guidelines.

Goins WP, Talbot TR, Schaffner W, Edwards KM, Craig AS, Schrag SJ, Van Dyke MK, Griffin MR. Goins WP, et al. Among authors: talbot tr. Obstet Gynecol. 2010 Jun;115(6):1217-1224. doi: 10.1097/AOG.0b013e3181dd916f. Obstet Gynecol. 2010. PMID: 20502293 Free PMC article.

10

Relationship between age and the risk of surgical site infection: a contemporary reexamination of a classic risk factor.

Talbot TR, Schaffner W. Talbot TR, et al. J Infect Dis. 2005 Apr 1;191(7):1032-5. doi: 10.1086/428627. Epub 2005 Feb 24. J Infect Dis. 2005. PMID: 15747235 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page